Background. The proposed mentored research program is an investigation of chemotherapeutics for malaria elimination led by Dr. Matthew Ippolito under the mentorship of Dr. Theresa Shapiro, an expert in antiparasitic pharmacology, and others. The project will join clinical pharmacology analytics with molecular and genetic approaches to establish the pharmacokinetics (PK, drug exposure) and pharmacodynamics (PD, drug effect) of first-line antimalarial agents for gametocyte clearance and protection against reinfection, and characterize their relative barriers to drug resistance. Dr. Ippolito will acquire expertise in advanced PK/PD methods and clinical trial conduct. At the end of the award period, he will be prepared to pursue a career as an independent investigator with a focus on field-based clinical pharmacology studies of antimalarial drugs both extant and novel. Candidate. Dr. Ippolito is a board-certified internist, infectious disease specialist, and clinical pharmacologist at the Johns Hopkins University School of Medicine, and PhD candidate in the Johns Hopkins University Graduate Training Program in Clinical Investigation with a background in malaria-related research. Research. The proposed research will leverage existing and forthcoming clinical trial specimens from study participants treated for uncomplicated malaria with one of two antimalarial drug combinations, artemether- lumefantrine or dihydroartemisinin-piperaquine. Specimens will be processed to generate PK data (drug concentration) and PD data (parasitological outcomes, drug resistance genotypes). PK and PD variables will be analyzed using compartmental and nonlinear mixed effects models. Environment and Funding. The research activities will be carried out at Johns Hopkins University and collaborators' institutions. The antiparasitic laboratories of the primary mentor, Theresa Shapiro, MD, PhD? former director of the Johns Hopkins Division of Clinical Pharmacology and previous head of its Clinical Pharmacology Analytical Laboratory?contain the requisite instrumentation for liquid chromatography-mass spectrometry PK analyses; and the laboratories of the Johns Hopkins Malaria Research Institute and its partners have state-of-the-art instruments for molecular diagnostics and genetic sequencing of malaria parasites. Relevance to Public Health. Malaria remains a major public health issue, with nearly a half-million deaths each year arising from over 200 million infections. Absent a sufficiently effective vaccine, antimalarial drugs remain a vital component of malaria control programs. Their incompletely characterized PK/PD profiles and unknown barriers to resistance translate to opportunities for further research to inform drug optimization. The proposed training plan and analytic approaches also have potential applications to new antimalarial agents as they emerge from the drug development pipeline.

Public Health Relevance

Antimalarial chemotherapeutics are critical to malaria control and elimination. However, current drug policies may not be optimal because they do not consider all of the relative advantages and disadvantages of different agents in clinical use because rigorous data are lacking. Specifically, the pharmacokinetics and pharmacodynamics that underpin the differential effects of first-line antimalarials on the transmissible stage of the malaria parasite and the variable durations of post-treatment protection against reinfection have not been adequately characterized in humans, nor have their relative barriers to resistance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
1K23AI139343-01A1
Application #
9891336
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
O'Neil, Michael T
Project Start
2020-02-13
Project End
2024-01-31
Budget Start
2020-02-13
Budget End
2021-01-31
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205